CHRNA4 and Parkinson disease: In Parkinson’s disease, a reduction in α7 receptor expression has been linked to impaired anti-inflammatory signaling and increased susceptibility to neurodegeneration [44], highlighting the importance of preserving or modulating nAChR expression as part of therapeutic strategies for neurodegenerative disorders [3,45].